Hologic Inc (HOLX)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Hologic Inc (HOLX)
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Key Insights
Critical company metrics and information
Share Price
$76.74Market Cap
$17.42 BillionTotal Outstanding Shares
226.94 Million SharesTotal Employees
7,063Dividend
No dividendIPO Date
March 1, 1990SIC Description
X-ray Apparatus & Tubes & Related Irradiation ApparatusHomepage
https://www.hologic.com
Historical Stock Splits
If you bought 1 share of HOLX before December 1, 2005, you'd have 4 shares today.
Execution Date | Split Amount |
---|---|
April 3, 2008 | 2-for-1 |
December 1, 2005 | 2-for-1 |
Cash Flow Statement
June 30, 2023 to June 29, 2024
Metric | Value |
---|---|
Net Cash Flow From Financing Activities, Continuing | $-1.26 Billion |
Exchange Gains/Losses | $900000.00 |
Net Cash Flow From Operating Activities, Continuing | $1.18 Billion |
Net Cash Flow | $-325.90 Million |
Net Cash Flow From Investing Activities, Continuing | $-241.30 Million |
Net Cash Flow From Operating Activities | $1.18 Billion |
Net Cash Flow From Financing Activities | $-1.26 Billion |
Net Cash Flow From Investing Activities | $-241.30 Million |
Net Cash Flow, Continuing | $-326.80 Million |
Income Statement
June 30, 2023 to June 29, 2024
Metric | Value |
---|---|
Net Income/Loss | $701.50 Million |
Benefits Costs and Expenses | $3.20 Billion |
Diluted Earnings Per Share | $2.93 |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Interest Expense, Operating | $118.30 Million |
Net Income/Loss Available To Common Stockholders, Basic | $701.50 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Diluted Average Shares | $237.52 Million |
Other Operating Expenses | $1.11 Billion |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Cost Of Revenue | $2.45 Billion |
Operating Income/Loss | $785.10 Million |
Basic Earnings Per Share | $2.95 |
Net Income/Loss Attributable To Parent | $701.50 Million |
Costs And Expenses | $3.20 Billion |
Income Tax Expense/Benefit, Deferred | $-61.20 Million |
Income Tax Expense/Benefit | $87.60 Million |
Income/Loss From Continuing Operations Before Tax | $734.10 Million |
Operating Expenses | $1.39 Billion |
Research and Development | $278.40 Million |
Income/Loss From Continuing Operations After Tax | $701.50 Million |
Gross Profit | $2.17 Billion |
Revenues | $3.99 Billion |
Basic Average Shares | $235.83 Million |
Balance Sheet
June 30, 2023 to June 29, 2024
Metric | Value |
---|---|
Intangible Assets | $687.60 Million |
Long-term Debt | $2.54 Billion |
Noncurrent Liabilities | $2.94 Billion |
Other Current Assets | $3.33 Billion |
Current Assets | $4.00 Billion |
Noncurrent Assets | $4.89 Billion |
Equity Attributable To Parent | $4.95 Billion |
Assets | $8.89 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Non-current Liabilities | $393.70 Million |
Other Non-current Assets | $3.68 Billion |
Liabilities | $3.94 Billion |
Current Liabilities | $1.00 Billion |
Other Current Liabilities | $800.40 Million |
Liabilities And Equity | $8.89 Billion |
Equity | $4.95 Billion |
Accounts Payable | $202.00 Million |
Inventory | $665.50 Million |
Fixed Assets | $528.80 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |
Related Companies
View additional S&P 500 companies similar to Hologic Inc (HOLX)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.